Interleukin Genetics reported an increase in revenues and a slightly decreased overall loss for the second quarter of 2016. For the quarter (end-June 30), the

In the next days and weeks, dentists are likely to hear one question over and over again from patients: “Do I still need to floss?”

Marketing company Amway will offer PerioPredict by Interleukin Genetics to its U.S. employees. The periodontal disease risk test will become available to about 5,000 Amway

Women who are pregnant are likely to have moderate to severe gingivitis and may need regular care to maintain their oral health and help avoid

Long-term marijuana use is associated with periodontal disease, according to a new study in JAMA Psychiatry. However, chronic pot smokers did not develop other health

Interleukin Genetics reported an increase in revenues for the first quarter of 2016. For the quarter (end-March 31), the company reported revenues of $961,000, up

Interleukin Genetics’ PerioPredict genetic risk test will now be covered by New England’s Comprehensive Benefit Administrators’ (CBA) Freedom Dental Plan after an April 21 agreement

Dentsply Sirona has announced four speakers for the periodontic/hygiene track at the inaugural Siroworld event in August. Heidi Arndt, RDH, will speak in two sessions:

Over the last 10 years that I have been treating halitosis, most of my patients were adults, but surprisingly, two of my most recent patients

Interleukin Genetics reported increased revenues for its fiscal fourth quarter of 2015 but also an increase in net loss, compared with the same quarter the

Interleukin Genetics has appointed experts to its clinical advisory board to advise the company on clinical programs that demonstrate the clinical benefits of targeted prevention